Literature DB >> 17636174

Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta).

J Sengupta1, P G L Lalitkumar, A R Najwa, D S Charnock-Jones, A L Evans, A M Sharkey, S K Smith, D Ghosh.   

Abstract

Maternal endometrial vascular endothelial growth factor (VEGF) is considered important in blastocyst implantation. However, there is no direct evidence to support this conjecture in the primate. In the present study, we have examined this hypothesis by testing whether immunoneutralization of VEGF during the peri-implantation stage of gestation affects embryo implantation in the rhesus monkey. Adult female animals (n = 36) during mated ovulatory cycles were randomly assigned to one of the experimental groups treated subcutaneously with either isotype-matched mouse immunoglobulin (group 1: control, n = 8) or monoclonal mouse antibody against VEGF-A (anti-VEGF Mab; group 2: 10 mg on day 5 after ovulation, n = 8; group 3: 20 mg on day 5 after ovulation, n = 8; group 4: 10 mg on day 10 after ovulation, n = 4; group 5: 10 mg on days 5 and 10 after ovulation, n = 8). Anti-VEGF Mab-treated animals in groups 2-4 did not show any marked inhibition in pregnancy establishment. On pooled analysis, however, anti-VEGF Mab administration in groups 2-5 (n = 28) resulted in a significant (P < 0.04) decline in the number of viable term pregnancy when compared with control animals. The observed difference was explained by the fact that 10 mg anti-VEGF Mab given to each animal on days 5 and 10 after ovulation in group 5 (n = 8) inhibited pregnancy establishment significantly (P < 0.02) when compared with control group 1. There was no significant change in serum concentrations of estradiol-17beta, progesterone, and free VEGF among groups. Furthermore, animals treated with anti-VEGF Mab (n = 8) as in group 5 revealed marked decrease in immunoreactive VEGF, fms-like tyrosine kinase-1, and kinase-insert domain region in trophoblast cells associated with shallow uterine invasion on day 13 of gestation when compared with samples from control group animals (n = 8). Thus, VEGF action is required for successful blastocyst implantation in the rhesus monkey.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636174     DOI: 10.1530/rep.1.01228

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  10 in total

1.  Effects of Erbuzhuyu Decoction Combined with Acupuncture on Endometrial Receptivity Are Associated with the Expression of miR-494-3p.

Authors:  Lan Yuan; Fen Feng; Zhu Mao; Jinzhu Huang; Yi Liu; Yulin Li; Rongxing Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-25       Impact factor: 2.629

2.  Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse.

Authors:  Nataki C Douglas; Hongyan Tang; Raul Gomez; Bronislaw Pytowski; Daniel J Hicklin; Christopher M Sauer; Jan Kitajewski; Mark V Sauer; Ralf C Zimmermann
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

Review 3.  The role of growth factors and cytokines during implantation: endocrine and paracrine interactions.

Authors:  Ozlem Guzeloglu-Kayisli; Umit Ali Kayisli; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2009-02-05       Impact factor: 1.303

4.  VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy.

Authors:  Minah Kim; Hyeung Ju Park; Jae Won Seol; Jeon Yeob Jang; Young-Suk Cho; Kyu Rae Kim; Youngsok Choi; John P Lydon; Francesco J Demayo; Masabumi Shibuya; Napoleone Ferrara; Hoon-Ki Sung; Andras Nagy; Kari Alitalo; Gou Young Koh
Journal:  EMBO Mol Med       Date:  2013-08-02       Impact factor: 12.137

5.  Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus.

Authors:  Carrie J Shawber; Lu Lin; Maria Gnarra; Mark V Sauer; Virginia E Papaioannou; Jan K Kitajewski; Nataki C Douglas
Journal:  Vasc Cell       Date:  2015-12-01

6.  Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.

Authors:  C V Bishop; D M Lee; O D Slayden; X Li
Journal:  J Ovarian Res       Date:  2017-07-06       Impact factor: 4.234

7.  Global, Survival, and Apoptotic Transcriptome during Mouse and Human Early Embryonic Development.

Authors:  D Haouzi; I Boumela; K Chebli; S Hamamah
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

8.  Profiles of cytokines secreted by isolated human endometrial cells under the influence of chorionic gonadotropin during the window of embryo implantation.

Authors:  Akhilesh Srivastava; Jayasree Sengupta; Alka Kriplani; Kallol K Roy; Debabrata Ghosh
Journal:  Reprod Biol Endocrinol       Date:  2013-12-17       Impact factor: 5.211

9.  VEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitment.

Authors:  Nataki C Douglas; Ralf C Zimmermann; Qian Kun Tan; Chantae S Sullivan-Pyke; Mark V Sauer; Jan K Kitajewski; Carrie J Shawber
Journal:  Vasc Cell       Date:  2014-08-01

10.  Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy.

Authors:  Jiahui Ding; Xiujuan Tan; Kunkun Song; Wenwen Ma; Jing Xiao; Yufan Song; Mingmin Zhang
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.